Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001987807 | SCV002222776 | pathogenic | Hypertrophic cardiomyopathy | 2022-07-19 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Leu1236Aspfs*5) in the MYBPC3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYBPC3 are known to be pathogenic (PMID: 19574547). This variant has not been reported in the literature in individuals affected with MYBPC3-related conditions. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1446713). |
Ambry Genetics | RCV002352637 | SCV002624135 | pathogenic | Cardiovascular phenotype | 2018-11-30 | criteria provided, single submitter | clinical testing | The c.3702_3703delAG pathogenic mutation, located in coding exon 33 of the MYBPC3 gene, results from a deletion of two nucleotides at nucleotide positions 3702 to 3703, causing a translational frameshift with a predicted alternate stop codon (p.L1236Dfs*5). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |